Attention-deficit/hyperactivity disorder: Diagnosis and treatment

Advances in Pediatrics

Volumn 51, Issue , 2004, Pages 289-327

  Reiff, Michael I ^a   Stein, Martin T ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; AMFEBUTAMONE; AMPHETAMINE; ANTIHYPERTENSIVE AGENT; ATOMOXETINE; CLONIDINE; DESIPRAMINE; DEXAMPHETAMINE; DEXMETHYLPHENIDATE; DOPAMINE; GUANFACINE; IMIPRAMINE; METHYLIN; METHYLPHENIDATE; MONOAMINE OXIDASE INHIBITOR; NORADRENALIN UPTAKE INHIBITOR; NORTRIPTYLINE; PSYCHOSTIMULANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ATTENTION DEFICIT DISORDER; BEHAVIOR; CHEMICAL ANALYSIS; CLINICAL TRIAL; CONSULTATION; DEMOGRAPHY; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; EVALUATION; FOLLOW UP; FUNCTIONAL DISEASE; GENETICS; HEADACHE; HEALTH CARE PERSONNEL; HUMAN; HYPERACTIVITY; IMPULSIVENESS; NERVOUSNESS; NEUROANATOMY; NEUROPSYCHOLOGY; PARENT; PRIMARY MEDICAL CARE; RATING SCALE; REVIEW; SCORING SYSTEM; SLEEP DISORDER; SOCIAL ASPECT; STOMACH PAIN; TEACHING; TRAINING; TREATMENT PLANNING; CHILD; PRACTICE GUIDELINE; PSYCHOLOGICAL ASPECT;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; HUMANS; PRACTICE GUIDELINES;

EID: 4644221787     PISSN: 00653101     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (116)

1. Still GF: Some abnormal psychical conditions in children. Lancet 1:1008-1012, 1077-1082, 1163-1168, 1902.
2. Hochman LB: Post-encephalitic behavior disorder in children. Johns Hopkins Hosp Bull 33:372-375, 1922.
3. Clements SD: Minimal brain dysfunction in children: Terminology and identification. Washington, DC, US Department of Health, Education and Welfare, 1966.
4. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 2. Washington, DC, American Psychiatric Association, 1968.
5. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3. Washington, DC, American Psychiatric Association, 1980.
6. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 3, revised. Washington, DC, American Psychiatric Association, 1987.
7. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4. Washington, DC, American Psychiatric Association, 1994.
8. Engle GL: The need for a new medical model: A challenge for biomedicine. Science 196:129-136, 1977.
9. Green M, Wong M, Atkins D: Diagnosis of Attention Deficit/Hyperactivity Disorder. Technical Review 3. Rockville, Md, US Department of Health and Human Services, Agency for Health Care Policy and Research, AHCPR Publication 99-0050, 1991.
10. Shaffer D, Fisher P, Dulcan MK, et al: The NIMH diagnostic interview schedule for children version 2.3 (DISC-2.3): Description, acceptability, prevalence rates, and performance in the MECA study. J Am Acad Child Adolesc Psychiatry 35:865-877, 1996.
11. Barkley RA, Fischer M, Edelbrock CS, et al: The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8-year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 29:546-555, 1990.
12. Biederman J, Faraone S, Milberger S, et al: A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry 53:437-446, 1996.
13. Mannuzza S, Klein R, Bessler A, et al: Adult psychiatric status of hyperactive boys grown up. Am J Psychiatry 155:493-498, 1998.
14. Stubbe DE: Attention-deficit/hyperactivity disorder. Overview: Historical perspective, current controversies and future directions. Child Adolesc Psychiatr Clin N Am 9:469-479, 2000.
15. Carey WB: What the multimodal treatment study of children with attention-deficit/hyperactivity disorder did and did not say about the use of methylphenidate for attention deficits. Pediatrics 105:863-864, 2000.
16. NIH Consensus Development Conference: Diagnosis and Treatment of Attention Deficit Hyperactivity Disorder. Washington, DC, National Institutes of Health Medical Education, 1998.
17. Barkley RA: International consensus statement on ADHD. J Am Acad Child Adolesc Psychiatry 41:1389, 2002.
18. Wasserman RC, Kelleher KJ, Bocian A, et al: Identification of attentional and hyperactivity problems in primary care: A report from pediatric research in office settings and the ambulatory sentinel practice network. Pediatrics 103:e38, 1999.
19. Angold A, Erkanli A, Costello EJ: Stimulant treatment for children: A community perspective. J Am Acad Child Adolesc Psychiatry 39:975-984, 2000.
20. Jensen P, Kettle L, Roper M, et al: Are stimulants overprescribed? Treatment of ADHD in 4 US communities. J Am Acad Child Adolesc Psychiatry 38:797-804, 1999.
21. Reiff MI, Stein MT: Attention-deficit/hyperactivity disorder evaluation and diagnosis: A practical approach in office practice. Pediatr Clin North Am 50:1019-1048, 2003.
22. Wolraich MI, Hannah JN, Baumgaertel A, et al: Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample. J Dev Behav Pediatr 19:162-168, 1998.
23. Bird H: The diagnostic classification, epidemiology, and cross-cultural validity of ADHD, in Jensen PS, Cooper J (eds): Attention Deficit Hyperactivity Disorder: State of the Science; Best Practices. Kingston, NJ, Civic Research Institute, 2002 pp 2-1 to 2-16.
24. Carlson C, Mann M: Attention-deficit/hyperactivity disorder, predominently inattentive sybtype. Child Adolesc Psychiatr Clin N Am 9:499-510, 2000.
25. Erlenmeyer-Kimmling N, Cornblatt B: Attentional measures in a study of children at high-risk for schizophrenia. J Psychiatr Res 14:93-98, 1978.
26. Mirsky AF, Duncan CC: A nosology of disorders of attention. Ann N Y Acad Sci 931:17-32, 2001.
27. Barkley R: ADHD and the Nature of Self-control. New York, Guilford Press, 1997.
28. Swanson J, Castellanos FX, Murias M, et al: Cognitive neuro-science of attention deficit hyperactivity disorder and hyperkinetic disorder. Curr Opin Neurobiol 8:263-271, 1998.
29. Volkow ND, Wang GJ, Fowler JS, et al: Effects of methylphenidate on regional brain glucose metabolism in humans: Relationship to dopamine D2 receptors. Am J Psychiatry 154:50-55, 1997.
30. Swanson JM, Castellanos FX: Biological bases of ADHD: Neuroanatomy, genetics, and pathophysiology, in Jensen PS, Cooper J (eds): Attention Deficit Hyperactivity Disorder: State of the Science; Best Practices. Kingston, NJ, Civic Research Institute, 2002, pp 7-1 to 7-20.
31. Castellanos FX, Lee PP, Sharp W, et al: Developmental trajectories of brain volume abnormalities in children and adolescents with attention-deficit/ hyperactivity disorder. JAMA 288:1740-1748, 2002.
32. Lou HC, Henriksen L, Bruhn P: Focal cerebral dysfunction in developmental learning disabilities. Lancet 335:8-11, 1990.
33. Vaida CJ, Austin G, Kirkorian G, et al: Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study. Proc Natl Acad Sci U S A 95:14494-14499, 1998.
34. Oades RD, Dittman-Balacar A, Schepker R, et al: Auditory event-related potentials (ERPs) and mismatch negativity (MMN) in healthy children and those with attention-deficit or Tourette/tic symptoms. Biol Psychol 43:163-185, 1996.
35. Goodman R, Stevenson J: A twin study of hyperactivity: II. The aetiological role of genes, family relationships, and perinatal adversity. J Child Psychol Psychiatry 30:691-709, 1989.
36. Willcut EG, Pennington BF, DeFries JC: Twin study of the etiology of comorbidity between reading disability and attention-deficit/hyperactivity disorder. Am J Med Genet 96:293-301, 2000.
37. Smalley SI, Bailey JN, Palmer CT, et al: Evidence that the dopamine D4 receptor is a susceptibility gene in attention deficit hyperactivity disorder. Mol Psychiatry 3:427-430, 1998.
38. Barr CL, Wigg KG, Bloom S, et al: Further evidence from haplotype analysis for linkage of the dopamine D4 receptor gene and attention-deficit hyperactivity disorder. Am J Med Genet 96:262-267, 2000.
39. Waldman ID, Rowe DC, Abramowitz A, et al: Association and linkage of the dopamine transporter gene and attention-deficit/hyperactivity disorder in children: Heterogeneity owing to diagnostic subtype and severity. Am J Hum Genet 63:1767-1776, 1998.
40. Ding YS, Fowler J, Volkow N, et al: Clinical drugs: Comparison of the pharmacokinetics of [11C]d-threo and 1-threo-methylphenidate in the human and baboon brain. Psychopharmacology 131:71-78, 1997.
41. Greenhill LL, and the Work Group on Quality Issues: Practice parameter for the use of stimulant medications in the treatment of children, adolescents and adults. J Am Acad Child Adolesc Psychiatry 41:26S-49S, 2002.
42. Arnsten AD, Steere JC, Hunt RD: The contribution of alpha 2-noradrenergic mechanisms of prefrontal cortical cognitive function: Potential significance for attention-deficit hyperactivity disorder. Arch Gen Psychiatry 53:448-455, 1996.
43. Pliszka SR, McCracken JT, Mass JW: Catecholamines in attention-deficit hyperactity disorder: Current perspectives. J Am Acad Child Adolesc Psychiatry 35:264-272, 1996.
44. Hinshaw SP: Is ADHD an impairing condition in childhood and adolescence, in Jensen PS, Cooper J (eds): Attention Deficit Hyperactivity Disorder: State of the Science; Best Practices. Kingston, NJ, Civic Research Institute, 2002, pp 5-1 to 5-21.
45. Wolraich MI, Hannah JN, Baumgaertel A, et al: Examination of DSM-IV criteria for attention deficit/hyperactivity disorder in a county-wide sample. J Dev Behav Pediatr 19:162-168, 1998.
46. Reiff MI, Stein MT: Attention-deficit/hyperactivity disorder evaluation and diagnosis: A practical approach in office practice. Pediatr Clin North Am 50:1019-1048, 2003.
47. Barkley RA, Fischer M, Edelbrock CS, et al: The adolescent outcome of hyperactive children diagnosed by research criteria: I. An 8 year prospective follow-up study. J Am Acad Child Adolesc Psychiatry 29:546-557, 1990.
48. Biederman J, Faraone S, Milberger S, et al: A prospective 4-year follow-up study of attention-deficit hyperactivity and related disorders. Arch Gen Psychiatry 53:437-446, 1996.
49. August GJ, Stewart MA, Holmes CS: A four-year follow-up of hyperactive boys with and without conduct disorder. Br J Psychiatry 143:192-198, 1983.
50. Biederman J, Newcorn J, Sprich S: Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety and other disorders. Am J Psychiatry 148:564-577, 1991.
51. Hinshaw SP: Externalizing behavior problems and academic under-achievement in childhood and adolescence: Causal relationships and underlying mechanisms. Psychol Bull 111:127-155, 1992.
52. Loeber R, Lahey BB, Winters A, et al: Oppositional defiant and conduct disorder: A review of the past 10 years, part I. J Am Acad Child Adolesc Psychiatry 40:1393-1400, 2000.
53. Jensen PS, Hinshaw SP, Swanson JM, et al: Findings from the NIMH multimodal treatment study of ADHD (MTA): Implications and applications for primary care providers. J Dev Behav Pediatr 22:60-73, 2001.
54. Reiff MI (ed): ADHD: A Complete and Authoritative Guide. Elk Grove Village, Ill, American Academy of Pediatrics, 2004.
55. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 4, text revision. Washington, DC, American Psychiatric Association, 2000.
56. American Academy of Pediatrics: The Classification of Child and Adolescent Mental Diagnoses in Primary Care: Diagnostic and Statistical Manual for Primary Care (DSM-PC) Child and Adolescent Version. Elk Grove Village, Ill, American Academy of Pediatrics, 1966.
57. American Academy of Pediatrics, Committee on Quality Improvement and Subcommittee on Attention-Deficit/Hyperactivity Disorder: Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder. Pediatrics 105:1158-1170, 2000.
58. American Academy of Pediatrics: Guidelines for Health Supervision Visits III. Elk Grove Village, Ill, American Academy of Pediatrics, 2002.
59. American Academy of Pediatrics: ADHD: Caring for Children With ADHD: A Resource Toolkit for Clinicians. AAP, 37925 Eagle Way, Chicago, IL 60678-1379. Phone: 888-227-1770.
60. American Academy of Pediatrics: Vanderbilt NICHQ ADHD Primary Care Initial Evaluation form, 2003, October 30, 2003.
61. Barkley RA, Murphy KR: Attention-Deficit/Hyperactivity Disorder: A Clinical Workbook. New York, Guilford Press, 1998.
62. Reynolds CR, Kamphaus RW: Behavior Assessment System for Children. Circle Pines, Minn., American Guidance Service, 1992.
63. Achenbach TM: Manual for the Child Behavior Checklist/4-18 and 1991 Profile. Burlington, Vt, University of Vermont, Department of Psychiatry, 1991.
64. Reiff MI, Stein MT: Attention-deficit/hyperactivity disorder evaluation and diagnosis: A practical approach in office practice. Pediatr Clin North Am 50:1019-1042, 2003.
65. Pelham WE: Psychosocial interventions for ADHD in Jensen PS, Cooper J (eds): Attention Deficit Hyperactivity Disorder: State of the Science; Best Practices. Kingston, NJ, Civic Research Institute, 2002, pp 12-2 to 12-24.
66. MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1073-1086, 1999.
67. Gillberg C, Melander H, von Knorring AL, et al: Long-term stimulant treatment of children with attention-deficit hyperactivity disorder symptoms: A randomized, double-blind placebo-controlled trial. Arch Gen Psychiatry 27:190-205, 1997.
68. Hechtman L, Abikoff H: Multimodal treatment plus stimulants vs stimulant treatment in ADHD children: Results from a two year comparative treatment study. Presented at the Annual Meeting of the American Academy of Child and Adolescent Psychiatry. New Orleans, La, October 17-22, 1995.
69. Bradley C: The behavior of children receiving Benzedrine. Am J Psychiatry 94:557-585, 1937.
70. Vitiello B, Jensen P: Medication development and testing in children and adolescents. Arch Gen Psychiatry 54:871-876, 1997.
71. NIH Consensus Statement: Diagnosis and treatment of attention deficit hyperactivity disorder (ADHD). NIH Consens Statement 16:1-37, 1998.
72. Patrick KS, Mueller RA, Gualtieri CT, et al: Pharmacokinetics and actions of methylphenidate, in Meltzer HY (ed): Psychopharmacology: A Third Generation of Progress. New York, Raven, 1987, pp 1387-1395.
73. Swanson J, Kinsbourne M, Roberts W, et al: Time-response analysis of the effect of stimulant medication on the learning ability of children referred for hyperactivity. Pediatrics 61:2-29, 1978.
74. Swanson J, Gupta S, Guinta D, et al: Acute tolerance to methylphenidate in the treatment of attention deficit hyperactivity disorder in children. Clin Pharmacol Ther 66:295-305, 1999.
75. Safer DJ, Allen RP: Absence of tolerance to the behavioral effects of methylphenidate in hyperactive and inattentive children. J Pediatr 115: 1003-1008, 1989.
76. Swanson J, Wigal S, Greenhill L, et al: Analog classroom assessment of Adderall in children with ADHD. J Am Acad Child Adolesc Psychiatry 37:1-8, 1998.
77. Abikoff H, Gittelman R: Hyperactive children treated with stimulants: Is cognitive training a useful adjunct? Arch Gen Psychiatry 42:953-961, 1985.
78. Ritchers J, Arnold L, Abikoff H, et al: The National Institute of Mental Health Collaborative Multisite Multimodal Treatment Study of Children With Attention-Deficit Hyperactivity Disorder (MTA): I. Background and rationale. J Am Acad Child Adolesc Psychiatry 34:987-1000, 1995.
79. Barkley R, McMurray M, Edelbroch C, et al: Side effects of MPH in children with attention deficit hyperactivity disorder: A systematic placebo-controlled evaluation. Pediatrics 86:184-192, 1990.
80. McMaster University Evidence-Based Practice Center: The Treatment of Attention-Deficit/Hyperactivity Disorder: An Evidence Report (Contract 290-97-0017). Washington, DC, Agency for Health Care Policy and Research, 1998.
81. Mannuza S, Klein R, Bonagura N, et al: Hyperactive boys almost grown up: V. Replication of psychiatric status. Arch Gen Psychiatry 48:77-83, 1991.
82. Barkley RA, Fischer M, Smallish L: Does the treatment of attention-deficit/hyperactivity disorder with stimulants contribute to drug use /abuse? A 13-year prospective study. Pediatrics 111:97-109, 2003.
83. Wilens TE, Faraone SV, Biederman J: Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A metaanalytic review of the literature. Pediatrics 111:179-185, 2003.
84. Castellanos X, Giedd J, Elia J, et al: Controlled stimulant treatment of ADHD and comorbid Tourette's syndrome: Effects of stimulant and dose. J Am Acad Child Adolesc Psychiatry 36:589-596, 1997.
85. Adesman AR: New medications for treatment of children with attention-deficit/hyperactivity disorder: Review commentary. Pediatr Ann 31:514-522, 2002.
86. Birmaher BB, Greenhill L, Cooper T, et al: Sustained release methylphenidate: Pharmacokinetic studies in ADDH males. J Am Acad Child Adolesc Psychiatry 28:768-772, 1989.
87. Pelham WE, Sturges H, Joza J: The effects of sustained release 20 and 10 mg Ritalin b.i.d. on cognitive and social behavior in children with attention deficit disorder. Pediatrics 80:491-501, 1989.
88. Wolraich M, Greenhill LL, Abikoff H, et al: Randomized controlled trial of OROS methylphenidate once a day in children with attention-deficit/ hyperactivity disorder. Pediatrics 108:883-892, 2001.
89. Auiler JF, Liu K, Lynch JM, et al: Effect of food on early drug exposure from extended-release stimulants: Results from the Concerta, Adderall XRfood evaluation (CAFÉ) study. Curr Med Res Opin 18:311-316, 2002.
90. Jensen P, Arnold L, Richters J, et al: 14-Month randomized clinical trial of treatment strategies for attention deficit hyperactivity disorder. Arch Gen Psychiatry 56:1073-1086, 1999.
91. Spencer TJ, Biederman MD, Wilens TE, et al: Novel treatments for attention-deficit/hyperactivity disorder in children. J Clin Psychiatry 63:16S-22S, 2002.
92. Jadad AR, Boyle M, Cunningham C, et al: Treatment of Attention-Deficit/ Hyperactivity Disorder. Evidence Report/Technology Assessment No 11. Rockville, Md, Agency for Healthcare Research and Quality, AHRQ Publication No 00-E005, 1999.
93. Spencer TJ, Biederman J, Coffey B, et al: A double-blind placebo comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 5:649-656, 2002.
94. Varley CK: Sudden death related to selected tricyclic antidepressants in children: Epidemiology, mechanisms and clinical implications. Paediatr Drugs 3:613-627, 2001.
95. Michelson D, Faries D, Wernicke J, et al: Atomoxetine in the treatment of children and adolescents with attention-deficit/hyperactivity disorder: A randomized, placebo-controlled, dose-response study. Pediatrics 108:E83, 2001.
96. Spencer T, Biederman J: Non-stimulant treatment for attention-deficit/ hyperactivity disorder. J Atten Disord 6:S109-S119, 2002.
97. Kratochvil CJ, Heiligenstein JH, Dittmann R, et al: Atomoxetine and methylphenidate treatment in children with ADHD: A prospective, randomized, open-label trial. J Am Acad Child Adolesc Psychiatry 41:776-784, 2002.
98. Michelson D, Allen AJ, Busner J, et al: Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomized, placebo-controlled study. Am J Psychiatry 159:1896-1901, 2002.
99. Conners CK, Casat CD, Gualtieri CT, et al: Bupropion hydrochloride in attention deficit disorder with hyperactivity. J Am Acad Child Adolesc Psychiatry 35:1314-1321, 1996.
100. Wilens TE, Spencer TJ, Biederman J, et al: A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 158:282-288, 2001.
101. Spencer TJ, Biederman J, Coffey B, et al: A double-blind placebo comparison of desipramine and placebo in children and adolescents with chronic tic disorder and comorbid attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 59:649-656, 2002.
102. Taylor FB, Russo J: Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. J Clin Psychopharmacol 21:223-228, 2001.
103. Hunt RD, Minderaa RB, Cohen DJ: The therapeutic effect of clonidine in attention deficit disorder with hyperactivity: A comparison with placebo and methylphenidate. Psychopharmacol Bull 22:229-236, 1986.
104. Hunt RD, Arnsten AD, Asbell MD: An open trial of guanfacine in the treatment of attention-deficit hyperactivity disorder. J Am Acad Child Adolesc Psychiatry 34:50-54, 1995.
105. Greydanus DE, Pratt HD, Sloane MA, et al: Attention-deficit/hyperactivity disorder in children and adolescents: Interventions for a complex costly clinical conundrum. Pediatr Clin North Am 50:1049-1092, 2003.
106. Scahill L, Chappell PB, Kim YS, et al: A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder. Am J Psychiatry 158:1067-1074, 2001.
107. Anastopoulos AD, Smith JM, Wien EE: Counseling and training parents, in Barkley RA (ed): Attention-Deficit/Hyperactivity Disorder: A Handbook for Diagnosis and Treatment, ed 2. New York, Guilford Press, 1998, pp 491-509.
108. Barkley RA: Taking Charge of ADHD: The Complete, Authoritative Guide for Parents, Revised Edition. New York, Guilford Press, 2000.
109. Kelley ML, McCain AP: Promoting academic performance in inattentive children: The relative efficacy of school-home notes with and without response-cost. Behav Modif 19:357-375, 1995.
110. Greene RW, Ablon JS, Goring JC: A transactional model of oppositional behavior underpinnings of the collaborative problem solving approach. J Psychosom Res 55:67-75, 2003.
111. MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 56:1073-1086, 1999.
112. Barkley RA: Defiant Children: A Clinician's Manual for Parent Training. New York, Guilford Press, 1987.
113. Forehand R, MacMahon R: Helping the Noncompliant Child: A Clinician's Guide to Parent Training. New York, Guilford Press, 1980.
114. American Academy of Pediatrics, Committee on Quality Improvement, Subcommittee on Attention-Deficit/Hyperactivity Disorder: Clinical practice guideline: Treatment of the school-age child with attention-deficit/ hyperactivity disorder. Pediatrics 108:1033-1044, 2001.
115. Fireman P, Friday GA, Gira C, et al: Teaching self-management skills to asthmatic children and parents in an ambulatory care setting. Pediatrics 68:341-348, 1981.
116. Jessop DJ, Stein REK: Providing comprehensive health care to children with chronic illness. Pediatrics 93:602-607, 1994.